Global Biopharma Leader Transforms Conference Intelligence with Evalueserve Partnership

The Challenge

A global biopharmaceutical company, renowned for its innovative approach across multiple therapeutic areas, faced a strategic roadblock in how it managed intelligence during major medical conferences. Its Medical Affairs, Clinical CI, and Commercial CI teams—each tasked with deriving critical insights—were operating independently, leading to redundant efforts, misaligned outputs, and fragmented reporting. 

Legacy platforms further compounded the issue. They were hard-coded, non-customizable, and too inflexible to support the real-time, context-specific needs of stakeholders. Insights were slow, generic, and difficult to act upon—especially when derived from high volumes of conference content. 

Crucially, there was no centralized platform that could support diverse stakeholder needs, accommodate different reporting lenses, or unify teams working across six distinct disease areas. As a result, intelligence generation lacked coordination, clarity, and speed—three things essential in fast-paced conference environments. 

The Solution

To overcome these challenges, the company partnered with Evalueserve to create a tailored platform that brought together insights from medical, clinical, and commercial teams. The goal was to deliver faster, more strategic intelligence during key medical conferences. 

Evalueserve started with a deep dive into existing systems and designed a flexible, user-friendly solution that enabled: 

  • Better collaboration across teams 
  • Centralized, real-time access  
  • Expert curation of high-volume conference content 
  • Tailored reporting for different stakeholders 

The result was a powerful platform that delivered timely, actionable insights to teams across all levels of the organization. 

Business Impact

By introducing the centralized, intelligent, and agile Insightsfirst platform, Evalueserve enabled the client to break down silos, scale insight delivery, and empower smarter decision-making—setting a new standard for how medical conference intelligence is captured, synthesized, and delivered. 

  • 5X broader conference coverage,

    spanning more content, more disease areas, and more stakeholder needs

  • 10X faster insight turnaround,

    ensuring key takeaways reached decision-makers during, not after, the event

  • 25% savings in conference-related investment,

    achieved through reduced redundancies and more efficient resource allocation

  • Smarter, unified intelligence

    that strengthened internal alignment and helped guide commercial and medical strategy in real time

Overview & Impact

A global biopharma company partnered with Evalueserve to streamline and unify its medical conference intelligence process. The result was faster insights, better team alignment, and significant cost savings.

0 X

Faster Conference Insights

0 %

Savings on Intelligence Efforts

Share: